» Articles » PMID: 30741356

Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients

Overview
Specialty Oncology
Date 2019 Feb 12
PMID 30741356
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Care delivery innovation is necessary to address the growing complexity of cancer care across specialties and integrate new diagnostics, treatments, and services into care delivery. Informed by Cancer Care Delivery Research (CCDR), multilevel intervention research, and other disciplines, this article describes the 4-step cancer care delivery innovation cycle. The cycle guides collaborative efforts of cancer clinicians, researchers, patients, and other stakeholders to systematically define care delivery problems and formulate, test, and implement care innovations to effectively address problems. We illustrate the 4 steps of the innovation cycle with the example of developing the 4R Oncology Model for colorectal cancer (4R is Right Information and Right Care for the Right Patient at the Right Time). The 4R is a multilevel intervention informed by CCDR, the team science, and lessons learned from other models, such as survivorship care planning. We offer additional considerations for balancing the need to innovate with concerns about constrained resources and overextended workforce. We suggest to focus on care delivery models which are synergistic with other efforts and do not require extensive information systems support in earlier cycles of development.

Citing Articles

Right Information, Right Care, Right Patient, Right Time: Community Preferences to Inform a Self-Management Support Tool for Upper Respiratory Symptoms.

Gutnick D, Lutz C, Lutz C, Mani K, Mani K, Weldon C Appl Clin Inform. 2024; 16(1):145-155.

PMID: 39472036 PMC: 11839252. DOI: 10.1055/a-2441-6016.


Advance Directives for Patients With Breast Cancer: Applying the Right Info/Right Care/Right Patient/Right Time Oncology Model.

Ossowski S, Lyon L, Linehan E, Gordon N, Egorova O, Mark B Perm J. 2023; 27(3):30-36.

PMID: 37255340 PMC: 10502389. DOI: 10.7812/TPP/22.177.


A Learning Health System Approach to Cancer Survivorship Care Among LGBTQ+ Communities.

Dunne W, Adebayo N, Danner S, Post S, OBrian C, Tom L JCO Oncol Pract. 2022; 19(1):e103-e114.

PMID: 36475752 PMC: 10166358. DOI: 10.1200/OP.22.00386.


Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions.

Liu R, Weldon C, Linehan E, Gordon N, Abbe T, Hennings M JCO Oncol Pract. 2022; 19(1):e125-e137.

PMID: 36178937 PMC: 10166419. DOI: 10.1200/OP.22.00287.

References
1.
Lee S, Clark M, Cox J, Needles B, Seigel C, Balasubramanian B . Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach. J Oncol Pract. 2016; 12(11):1029-1038. PMC: 5356468. DOI: 10.1200/JOP.2016.013664. View

2.
Lee L, Cheung W, Atkinson E, Krzyzanowska M . Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2010; 29(1):106-17. DOI: 10.1200/JCO.2010.31.3049. View

3.
Noyes K, Monson J, Rizvi I, Savastano A, Green J, Sevdalis N . Regional Multiteam Systems in Cancer Care Delivery. J Oncol Pract. 2016; 12(11):1059-1066. PMC: 5455419. DOI: 10.1200/JOP.2016.013896. View

4.
Edwards M, Campbell I, Lawrenson R, Kuper-Hommel M . Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2017; 165(1):17-39. DOI: 10.1007/s10549-017-4295-4. View

5.
Cukier P, Santini F, Scaranti M, Hoff A . Endocrine side effects of cancer immunotherapy. Endocr Relat Cancer. 2017; 24(12):T331-T347. DOI: 10.1530/ERC-17-0358. View